Nasdaq Knsa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq knsa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Knsa Today - Breaking & Trending Today

Wedbush Reaffirms "Outperform" Rating for Kiniksa Pharmaceuticals (NASDAQ:KNSA)

Wedbush reaffirmed their outperform rating on shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA – Free Report) in a research note published on Tuesday morning, RTT News reports. They currently have a $30.00 price objective on the stock. Wedbush also issued estimates for Kiniksa Pharmaceuticals’ Q2 2024 earnings at ($0.06) EPS, Q3 2024 earnings at ($0.02) EPS, Q4 […] ....

Michaelr Megna , News Ratings For Kiniksa Pharmaceuticals Daily , Capital Management Inc , Kiniksa Pharmaceuticals Ltd , Dynamic Technology Lab Private Ltd , Institutional Trading Of Kiniksa Pharmaceuticals , Kiniksa Pharmaceuticals , Advisors Inc , Kiniksa Pharmaceuticals Trading , Kiniksa Pharmaceuticals Company Profile , Victory Capital Management Inc , China Universal Asset Management Co , Free Report , Get Free Report , Universal Asset Management , Capital Management , Technology Lab Private Ltd , Kiniksa Pharmaceuticals Daily , Nasdaq Knsa , Reiterated Rating ,

Wedbush Weighs in on Kiniksa Pharmaceuticals, Ltd.'s Q1 2025 Earnings (NASDAQ:KNSA)

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) – Equities research analysts at Wedbush issued their Q1 2025 earnings per share (EPS) estimates for Kiniksa Pharmaceuticals in a research note issued to investors on Wednesday, February 28th. Wedbush analyst D. Nierengarten anticipates that the company will post earnings of ($0.17) per share for the quarter. Wedbush […] ....

Johnf Paolini , Mark Ragosa , Kiniksa Pharmaceuticals Ltd , Kiniksa Pharmaceuticals Company Profile , News Ratings For Kiniksa Pharmaceuticals Daily , Altshuler Shaham Ltd , Kiniksa Pharmaceuticals Price Performance , China Universal Asset Management Co , Kiniksa Pharmaceuticals , Securities Exchange Commission , Royal Bank , Advisors Inc , Lazard Asset Management , Free Report , Kiniksa Pharmaceutical , Asset Management , Shaham Ltd , China Universal Asset Management , Universal Asset Management , Exchange Commission , Get Free Report , Kiniksa Pharmaceuticals Daily , Nasdaq Knsa , Earnings Estimates ,

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Sets New 1-Year High at $20.94

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) shares hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $20.94 and last traded at $20.83, with a volume of 197612 shares traded. The stock had previously closed at $20.16. Analyst Ratings Changes KNSA has been the topic of […] ....

Johnf Paolini , Michaelr Megna , Tower Research Capital , Altshuler Shaham Ltd , News Ratings For Kiniksa Pharmaceuticals Daily , Lazard Asset Management , Kiniksa Pharmaceuticals Stock Performance , Kiniksa Pharmaceuticals Ltd , Royal Bank , Securities Exchange Commission , Advisors Inc , Kiniksa Pharmaceuticals , Get Free Report , Exchange Commission , Research Capital , Asset Management , Shaham Ltd , Kiniksa Pharmaceuticals Daily , Nasdaq Knsa ,